 |
Ensuring access to vaccines and related products =>> Managing process for country support from Vaccine Fund =>>
Coverage surveys carried out when needed for allocation of performance-based grants
| Status |
Achievement of overall target |
| Delayed |
Consultants trained, tool for analysis finished.
One coverage survey (Mozambique) conducted, two more (Uzbekistan and East Timor planned).
C๔te dIvoire and Yemen were cancelled.
|
Responsible entity: Secretariat
Completed by: December 2005
Total budget: $649,625
Target description and how it will help reach GAVI milestones
Reward disbursement is conditional to external verification of coverage. Countries that fail their first DQA can choose to undertake a coverage survey.
ACCESS MILESTONE: With successful DQA and improved performance, countries will get continued funding and be able to further increase coverage.
Justification for selection of activities
The Board has decided that coverage surveys may be used to externally validate coverage data in countries that fail DQA. If the coverage survey confirms the reported DTP3 in the JRF, the country will be able to access performance-based funding.
ACTION PLAN | Activities | Budget | Coordinating partner/ support partners | Expected outcomes | | Coordinate with countries and implementing agency (WHO) and organize the review by the IRC | $185,607 | Secretariat WHO | All identified countries will have conducted a coverage survey.
The number of countries to conduct such a survey is not yet known. We think it could be 4 in 2004 | | Coordinate with countries and implementing agency (WHO) and organize the review by the IRC | $464,018 | Secretariat WHO | All identified countries will have conducted a coverage survey.
The number of countries to conduct such a survey is not yet known. We think it could be 10 in 2005 |
Detailed information on activities
The coverage surveys will be managed by WHO.
|
|
|
|
Targets by priority area
Ensuring access to vaccines and related products
==>> Procurement/Supply of existing products
==>> Development and introduction of new, near-term products
==>> Managing process for country support from Vaccine Fund
All eligible countries that qualify and are interested in GAVI/VF support for ISS, new vaccines and injection safety, will have applied and will have been approved based on satisfactory proposals and progress reports.
External Data Quality Audits (DQAs) conducted in relevant countries.
Coverage surveys carried out when needed for allocation of performance-based grants
Securing long-term financing
==>> Financial sustainability
==>> Recapitalization of The Vaccine Fund
Strategic planning & monitoring
==>> Setting priorities
==>> Monitoring progress
Other
==>> Alliance coordination
Strengthening service delivery
==>> Health information and monitoring systems
==>> Contributing to alleviation of system-wide barriers
==>> Enhanced efforts in large population countries
|
|